IRCT20130903014551N12尚未招募未知
The effect of oat consumption on hepatic and blood glucose control indices and lipid profile in patients with non-alcoholic fatty liver
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Grade 2,3,4 non alcoholic fatty liver disease by ultrasound
- •The level of liver enzymes should be between normal up to 2 times than average level
- •A person should not consume alcohol or use less than 30 grams for men and 20 grams for women
- •Absence of pregnancy and breastfeeding
- •Absence of liver cirrhosis
- •Not following a special diet
- •Absence of malignancy and underlying diseases
- •Not taking insulin in diabetic patients
- •BMI should be between 25-40 kg/m²
排除标准
- •Reluctance to consume oats
- •Starting a new drug or changing the dose of previous drugs related to fatty liver in the last two months
研究者
相似试验
已完成
不适用
Effects of oat consumption on metabolism and gut microbiome in individuals with metabolic syndrome – a human dietary intervention trialE88.9Metabolic disorder, unspecifiedDRKS00022169Rheinische Friedrich-Wilhelms-Universität Bonn Institut für Ernährungs- und Lebensmittelwissenschaften/ Abteilung Ernährung und Mikrobiota68
已完成
不适用
The effects of a high oat diet on risk factors of heart disease and their link with gut healthCirculatory SystemCardiovascular diseaseISRCTN11665494niversity of Aberdeen60
已完成
不适用
Health Effects of Oats and Oat Bioactive in HumanPostprandial Glucose RegulationNCT03830736Lund University24
已完成
不适用
Health Effects of Oat and Oat Polar Lipids in HumanPostprandial Glucose RegulationNCT05139355Lund University20
已完成
不适用
Health Effects of Oat Bioactives (Betaglucan) in HumanHealthyNCT05801653Lund University20